The 14th International Congress on Lipid & Atherosclerosis (ICoLA)

The 14th International Congress on Lipid & Atherosclerosis (ICoLA) is organized by Korean Society of Lipid and Atherosclerosis (KSoLA), PLANBEAR and will be held from Sep 11 - 13, 2025 at Conrad Seoul, Yeongdeungpo-gu, Seoul, South Korea.

Theme: “Advancing Care in Lipids, Obesity, Glucose, and Blood Pressure: Exploring Innovative Therapies and Their Clinical Impact”

Description:
ICoLA 2025 expands its scientific vision beyond lipidology to encompass a comprehensive range of cardiometabolic risk factors. This broadened scope reflects our commitment to integrated strategies for the prevention and treatment of cardiovascular and metabolic diseases.

This year’s scientific program includes plenary and keynote lectures by global experts in lipid metabolism, vascular biology, and cardiometabolic disease management. These sessions will highlight recent advances in both basic science and clinical care, offering diverse perspectives from across the globe.

Further enhancing our global relevance, ICoLA 2025 will host joint symposia in collaboration with leading international societies, including the European Atherosclerosis Society (EAS), Japanese Atherosclerosis Society (JAS), and Canadian Society of Atherosclerosis, Thrombosis and Vascular Biology (CSATVB). These collaborative sessions will provide an exceptional opportunity to share scientific insights and foster global academic exchange.

In addition to plenary and keynote lectures, ICoLA 2025 will feature symposia, oral and poster presentations, and educational forums. Special emphasis will be placed on supporting young investigators, providing them with opportunities to present their work and engage with leaders in the field.